Vivos TherapeuticsVVOS
13F holders, Q1 2024 (March 31)16holders
$4.74avg. 13F price*
At the end of Q1 2024, 16 institutions reported holding Vivos Therapeutics Inc. (VVOS) in their 13F filings. The largest holders were Armistice Capital, LLC ($500K), Commonwealth Equity Services, LLC ($72K) and Vanguard Group Inc. ($51K).
- Company
- Vivos Therapeutics Inc.
- CUSIP
- 92859E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $73K |
| Exits | 3 | $624K |
Ownership 16 holders
| Armistice Capital, LLC | 0.01% | Add +81.7% | 103,582 | $500K |
| Commonwealth Equity Services, LLC | 0.00% | New | 15,000 | $72K |
| Vanguard Group Inc. | 0.00% | No change | 10,579 | $51K |
| NFSG Corp | 0.00% | Add +50.6% | 1,950 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +0.6% | 1,729 | $8K |
| Signaturefd, LLC | 0.00% | No change | 547 | $3K |
| Group One Trading LLC | 0.00% | Reduce -41.2% | 228 | $1K |
| Blue Trust, Inc. | 0.00% | New | 160 | $773 |
| Bank of America Corp. | 0.00% | New | 80 | $386 |
| Morgan Stanley | 0.00% | No change | 67 | $324 |
| Global Retirement Partners, LLC | 0.00% | No change | 23 | $111 |
| Kozak & Associates, Inc. | 0.00% | No change | 49 | $111 |
| Credit Agricole S A | 0.00% | No change | 2,365 | $63 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 8 | $39 |
| Wells Fargo & Company | 0.00% | No change | 7 | $34 |
| Royal Bank of Canada | 0.00% | No change | 7 | $0 |
"% of holder's portfolio" is VVOS's weight in each manager's 13F, not the share of Vivos Therapeutics Inc. the manager owns.